267875-58-1 Usage
Uses
Used in Pharmaceutical Synthesis:
1,2-Benzisoxazole-5-methanamine,3-methyl-(9CI) is used as a key intermediate in the synthesis of pharmaceuticals for its unique chemical structure and properties.
Used in Agrochemical Synthesis:
1,2-Benzisoxazole-5-methanamine,3-methyl-(9CI) is used as a building block in the development of agrochemicals, contributing to the creation of effective compounds for agricultural applications.
Used in Antidepressant Research:
1,2-Benzisoxazole-5-methanamine,3-methyl-(9CI) is used as a potential antidepressant agent in research studies, due to its demonstrated biological activities and potential therapeutic uses.
Used in Scientific Applications:
1,2-Benzisoxazole-5-methanamine,3-methyl-(9CI) is utilized in various scientific applications, including the study of its chemical properties and the exploration of its potential uses in different fields.
Check Digit Verification of cas no
The CAS Registry Mumber 267875-58-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,7,8,7 and 5 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 267875-58:
(8*2)+(7*6)+(6*7)+(5*8)+(4*7)+(3*5)+(2*5)+(1*8)=201
201 % 10 = 1
So 267875-58-1 is a valid CAS Registry Number.
267875-58-1Relevant academic research and scientific papers
Multicyclic bis-amide MMP inhibitors
-
Page/Page column 101, (2008/06/13)
The present invention relates generally to bis-amide group containing pharmaceutical agents, and in particular, to multicyclic bis-amide MMP-13 inhibitor compounds. More particularly, the present invention provides a new class of MMP-13 inhibiting compounds, containing a pyrimidinyl bis-amide group in combination with a heterocyclic moiety, that exhibit an increased potency and solubility in relation to currently known bis-amide group containing MMP-13 inhibitors.
Thrombin inhibitors
-
, (2008/06/13)
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: or a pharmaceutically acceptable salt thereof, wherein b is NY or O; c is CY2or N; d is CY3or N; e is CY4or N; f is CY5or N; g is CY6or N; Y4, Y5, and Y6are independently hydrogen, C1-4alkyl, or halogen; Y1and Y2are independently hydrogen, C1-4alkyl, C3-7cycloalkyl, halogen, NH2, OH or C1-4alkoxy, and Y3is hydrogen, C1-4alkyl, C3-7cycloalkyl, halogen, —CN, NH2, OH or C1-4alkoxy; A is and W, W1, R1, R3, R4, R5, X and Z are defined in the specification.
